TeraView announces first order into the Japanese pharmaceutical market

TeraView, the pioneer and leader in terahertz technology and solutions for the pharmaceutical and life science industry, and Bruker Optics, the world leader in analytical instrumentation, have deployed the first commercial Terahertz imager in Japan to aid in the development of new pharmaceutical tablets and other solid dosage forms, as well as root cause analysis in manufacture.

Takeda Pharmaceutical Company Limited, Japan’s largest pharmaceutical company, has recently acquired the terahertz tablet imaging system, TPI imaga 2000, which is the first of its kind deployed in Japan. TeraView Ltd works closely with Bruker Optics in Japan and throughout Asia to supply its customers with total solutions to their needs in pharmaceutical R&D and manufacture, and provide vital on-going support and optimisation of the technology to meet evolving customer requirements.

Commenting on this success, Dr Don Arnone, CEO of TeraView said “This order has significance because it gives Takeda access to innovative Terahertz tablet imaging technology, that will assist in the development of new and better drugs. For TeraView it is a significant breakthrough in its goal to supply its technology to leading Japanese pharmaceuticals, and represents another addition to the list of customers using Terahertz solutions to address unmet needs in dosage form development and manufacture”.